<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00529945</url>
  </required_header>
  <id_info>
    <org_study_id>CA0012</org_study_id>
    <nct_id>NCT00529945</nct_id>
  </id_info>
  <brief_title>PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness</brief_title>
  <acronym>Paradigm IV</acronym>
  <official_title>The Paradigm IV Trial - PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cierra</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cierra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary object of this study is to demonstrate the continued safety and performance of
      the PFx Closure System when utilized for patients with PFOs suffering from cryptogenic
      stroke, transient ischemic attack, migraine or decompression illness.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Anticipated">December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PFO closure at 6 months post procedure.</measure>
    <time_frame>6 months post procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PFO closure at 30 days and 12 months post procedure. AE event rate for all subjects. Measurement of migraine severity or frequency at 6 and 12 months post procedure for subjects enrolled due to diagnosis of migraine.</measure>
    <time_frame>30 days; 6 and 12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>PFO</condition>
  <condition>Stroke</condition>
  <condition>Transient Ischemic Attack</condition>
  <condition>Migraine</condition>
  <condition>Decompression Illness</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PFx Closure System</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 65 years old

          -  PFO with one or more of:

               -  Cryptogenic stroke,

               -  TIA or embolism,

               -  History of severe migraine headaches, or

               -  History of severe decompression illness.

        Exclusion Criteria:

          -  In appropriate anatomy (vascular or cardiac) or inappropriate medical condition for
             PFO closure and study medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Sievert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Center Frankfurt, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular Center Frankfurt Sankt katharinen</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2007</study_first_submitted>
  <study_first_submitted_qc>September 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2007</study_first_posted>
  <last_update_submitted>December 18, 2007</last_update_submitted>
  <last_update_submitted_qc>December 18, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2007</last_update_posted>
  <responsible_party>
    <name_title>Peggy McLaughlin</name_title>
    <organization>Cierra, Inc.</organization>
  </responsible_party>
  <keyword>PFO</keyword>
  <keyword>Stroke</keyword>
  <keyword>Transient Ischemic Attack</keyword>
  <keyword>Migraine</keyword>
  <keyword>Decompression Illness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

